Tarsadia Capital, LLC Biolife Solutions Inc Transaction History

Tarsadia Capital, LLC

  • $15.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$16.04 - $28.94 $7.02 Million - $12.7 Million
-437,521 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$9.2 - $17.06 $368,000 - $682,400
-40,000 Reduced 8.38%
437,521 $7.15 Million
Q1 2020

May 14, 2020
BUY
$8.36 - $17.03 $3.99 Million - $8.13 Million
477,521 New
477,521 $4.54 Million

Others Institutions Holding BLFS

# of Institutions
198
Shares Held
44.9M
Call Options Held
8.2K
Put Options Held
4K
View Full List

About BIOLIFE SOLUTIONS INC

BLFS Quotes by TradingView
  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.17B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Tarsadia Capital, LLC Portfolio

Follow Tarsadia Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarsadia Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tarsadia Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email